Patient Consent Form - Treatment - New York
PATIENT CONSENT TO MEDICAL TREATMENT
(New York – Comprehensive Form)
TABLE OF CONTENTS
- Document Header
- Definitions
-
Operative Provisions
3.1 Consent to Treatment
3.2 Disclosure of Material Information
3.3 Voluntary Consent & Withdrawal Rights
3.4 Care Instructions -
Representations & Warranties
- Covenants & Restrictions
- Care Continuity
-
Risk Allocation
7.1 No Waiver of Patient Rights
7.2 Force Majeure / Emergency Deviation -
Dispute Resolution
- General Provisions
- Execution Block
1. DOCUMENT HEADER
1.1 Title. Patient Consent to Medical Treatment (the “Agreement”).
1.2 Parties.
(a) “[PROVIDER LEGAL NAME],” a health-care provider duly licensed under the laws of the State of New York (“Provider”); and
(b) “[PATIENT FULL LEGAL NAME]” or the Patient’s Authorized Representative, as applicable (“Patient”).
1.3 Recitals.
A. Provider proposes to furnish certain medical, surgical, diagnostic, therapeutic, or other health-care services to Patient (collectively, the “Treatment”).
B. Patient desires to receive such Treatment based on informed consent, consistent with N.Y. Pub. Health Law § 2805-d and other applicable law.
C. The parties therefore enter into this Agreement as of the Effective Date defined below.
1.4 Effective Date. “[DATE]”.
1.5 Governing Law / Jurisdiction. This Agreement and all disputes arising hereunder shall be governed by the laws of the State of New York without regard to its conflict-of-laws principles (“Governing Law”). See Section 8 for forum and dispute resolution provisions.
2. DEFINITIONS
For purposes of this Agreement, capitalized terms have the meanings set forth below. Defined terms appear alphabetically for ease of reference.
2.1 “Authorized Representative” – An individual legally authorized to make health-care decisions on behalf of the Patient, including but not limited to a health-care proxy, parent of a minor, or court-appointed guardian.
2.2 “Capacity” – A Patient’s ability, as determined by Provider in accordance with clinical judgment and applicable law, to understand relevant information, appreciate foreseeable consequences, and make an informed, voluntary decision.
2.3 “Informed Consent” – A decision by Patient (or Authorized Representative) to accept the proposed Treatment after receiving and understanding adequate information regarding the procedure, alternatives, risks, benefits, and consequences of non-treatment.
2.4 “Material Risk” – A reasonably foreseeable risk of the proposed Treatment or a recognized alternative that a reasonable medical practitioner would disclose under similar circumstances.
2.5 “Minor” – An individual under eighteen (18) years of age who has not otherwise attained the legal capacity to consent pursuant to N.Y. Pub. Health Law §§ 2504, 2781, or other applicable provisions.
2.6 “Treatment” – The specific medical, surgical, diagnostic, therapeutic, or other health-care services described in Section 3.1, including all related anesthesia, pathology, laboratory, radiological, pharmaceutical, nursing, telemedicine, and ancillary services.
3. OPERATIVE PROVISIONS
3.1 Consent to Treatment
(a) Description. Patient hereby consents to the following Treatment:
- Procedure/Service: “[DESCRIBE IN LAY TERMS – e.g., ‘Laparoscopic Cholecystectomy’]”
- Treating Clinician(s): “[NAME & CREDENTIALS]”
- Location: “[FACILITY NAME & ADDRESS]”
(b) Ancillary Services. Patient further consents to such ancillary, diagnostic, or therapeutic services, including anesthesia and blood transfusion, as Provider deems reasonably necessary in the course of Treatment.
3.2 Disclosure of Material Information
Provider has disclosed, and Patient acknowledges receipt and understanding of, the following information:
- Diagnosis/Indication for Treatment.
- Purpose and expected outcome.
- Material Risks (including quantitative data where available).
- Likely benefits.
- Reasonable alternatives, including the option of no treatment and associated risks.
- Name(s) of all physicians with significant roles.
- Estimated recovery period and post-treatment requirements.
- Capacity determination, interpreter services provided, and opportunity to ask questions.
3.3 Voluntary Consent & Withdrawal Rights
(a) Voluntary Decision. Patient affirms that consent is given voluntarily without coercion.
(b) Right to Withdraw. Patient may revoke consent orally or in writing at any time before or during Treatment, subject to emergent circumstances.
(c) Consequences of Withdrawal. Provider will explain the medical consequences of stopping Treatment and steps needed to do so safely.
3.4 Care Instructions
Provider has explained any preparation needed before Treatment and the expected follow-up care. Patient may ask questions about these instructions.
4. REPRESENTATIONS & WARRANTIES
4.1 Provider Representations
(a) Licensure & Accreditation. Provider and participating clinicians are duly licensed in New York and maintain requisite certifications.
(b) Standard of Care. Provider will perform Treatment in accordance with prevailing professional standards.
4.2 Patient Representations
(a) Accuracy of Information. Patient has disclosed complete and accurate medical history, medications, allergies, and other material facts.
(b) Capacity. Patient affirms Capacity to consent or, if lacking, that an Authorized Representative executes this Agreement with full authority.
(c) Understanding. Patient has had all questions answered to satisfaction and understands the disclosed information.
4.3 Survival. Representations and warranties survive completion or termination of Treatment to the extent necessary to enforce this Agreement.
5. COVENANTS & RESTRICTIONS
5.1 Patient Covenants
(a) Follow-Up Care. Patient will adhere to Provider’s post-treatment instructions and attend follow-up appointments.
(b) Clinical Information. Patient will tell Provider about material changes in symptoms, medications, or medical history relevant to Treatment.
5.2 Provider Covenants
(a) Confidentiality. Provider will protect Patient’s Protected Health Information in compliance with HIPAA and applicable state privacy laws.
(b) Notice of Material Changes. Provider will notify Patient of any material change in Treatment plan where practicable.
6. CARE CONTINUITY
6.1 Withdrawal or Refusal
If Patient refuses or withdraws consent, Provider will document the decision, explain material medical consequences, and arrange a clinically safe transition when needed.
6.2 Follow-Up
Provider will give Patient appropriate post-treatment instructions and explain when to seek additional care.
7. RISK ALLOCATION
7.1 No Waiver of Patient Rights
Nothing in this consent waives or limits any right or remedy available to Patient under New York law.
7.2 Force Majeure / Emergency Deviation
Provider may deviate from the Treatment plan without further consent if emergent circumstances threaten life or substantial bodily function and obtaining consent is impracticable.
8. DISPUTE RESOLUTION
8.1 Court Proceedings. A dispute may be brought in a court with jurisdiction and proper venue under New York law. This treatment consent does not require arbitration or waive any jury-trial right.
8.2 Injunctive Relief. Either party may seek limited injunctive relief to preserve the status quo pending final resolution.
9. GENERAL PROVISIONS
9.1 Amendments & Waivers. Changes to the contractual terms must be in writing and signed by both parties. This requirement does not limit Patient's right under Section 3.3(b) to revoke consent to Treatment orally or in writing.
9.2 Severability. Invalid or unenforceable provisions shall be reformed to the minimum extent necessary; remaining provisions remain in full force.
9.3 Entire Agreement. This Agreement, including any attachments and Disclosure Schedules, constitutes the complete understanding, superseding all prior discussions.
9.4 Counterparts; Electronic Signatures. Executed in multiple counterparts, each deemed an original. Signatures transmitted electronically (e.g., DocuSign) are binding.
9.5 Notices. Notices under this Agreement shall be in writing and delivered via (i) certified mail, return receipt requested; (ii) nationally recognized courier; or (iii) secure electronic means with confirmation, to the addresses set forth below.
10. EXECUTION BLOCK
IN WITNESS WHEREOF, the parties execute this Agreement as of the Effective Date.
A. Patient / Authorized Representative
Signature: ______________________________
Name: __________________________________
Relationship (if not Patient): ____________
Address: ________________________________
Date: ___________________________________
B. Provider
Authorized Clinician Signature: ___________
Name & Credentials: ______________________
Title: ___________________________________
Date: ___________________________________
C. Interpreter (if applicable)
I certify that I have accurately translated the information and questions between Provider and Patient.
Signature: ______________________________
Name & Language: _______________________
Date: ___________________________________
D. Witness (if required by facility policy)
Signature: ______________________________
Name: __________________________________
Date: ___________________________________
E. Notary Acknowledgment (optional / if required for certain procedures)
State of New York )
County of __________) ss.:
On the ____ day of __________, 20__, before me, the undersigned, a Notary Public in and for said state, personally appeared _______________________, proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the foregoing instrument and acknowledged that s/he executed the same.
Notary Public Signature: ___________________
My Commission Expires: ___________________
About this template
- Last updated
- October 30, 2026
- Jurisdiction
- New York
- Category
- Healthcare & Medical
These templates cover the everyday paperwork that happens between patients, providers, and health plans: consent forms, medical record authorizations, directives for end-of-life care, and requests to approve or deny treatment. Getting them right matters because they document medical decisions, release sensitive health information, and often have to meet both federal privacy rules and state-specific requirements. A form that is missing a required disclosure can be rejected by a provider or challenged later in court.
Not legal advice
This template is provided for informational purposes. We recommend having an attorney review any legal document before signing, especially for high-value or complex matters.
Checked against the law it cites
The statutes this template relies on are listed under Legal authority.
Matter of New York City Asbestos Litig., 32 Misc. 3d 161, 168 (Sup. Ct. N.Y. Cnty. 2011) (checked October 14, 2026): "New York has no limitation on the amount of such recovery, whereas Oregon's Damages Cap Law limits such recovery to $500,000."
10 NYCRR § 405.7(b)(9) (checked October 30, 2026): "as a reasonable practitioner under similar circumstances would disclose"
10 NYCRR § 405.7(b)(10) (checked October 30, 2026): "refuse treatment to the extent permitted by law"
N.Y. Public Health Law § 18-c (checked October 29, 2026): "shall be obtained separately from such patient's consent to pay for the services"
Draft your Patient Consent Form - Treatment in the editor
Answer a few questions, let the AI editor draft each section from your answers, review it, and download Word and PDF. $99 one time, or $249 per month for every document and every Ezel app.